Alembic Pharma announces US FDA tentative approval for Ivosidenib tablets 250 mg
The approved ANDA is therapeutically equivalent to the RLD product, Tibsovo Tablets, 250 mg, of Servier Pharmaceuticals
Recover your password.
A password will be e-mailed to you.
Recover your password.
A password will be e-mailed to you.